Related Experiment Video
Updated: Aug 8, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Extracellular ATP and bradykinin increase cGMP in vascular endothelial cells via activation of PKC
A F Castro1, C Amorena, A Müller
1Instituto de Investigaciones Cardiológicas, Facultad de Medicina, Universidad de Buenos Aires, 1122 Buenos Aires, Argentina.
Insights
Endothelium-dependent vasodilation involves nitric oxide (NO) and cyclic guanosine monophosphate (cGMP). This study shows protein kinase C (PKC) activation is crucial for ATP and bradykinin to increase cGMP levels in endothelial cells.
Area of Science:
- Vascular Biology
- Cell Signaling
- Biochemistry
Background:
- Vasodilation relies on nitric oxide (NO), the endothelium-dependent relaxing factor (EDRF).
- EDRF release elevates cyclic guanosine monophosphate (cGMP) in endothelial and smooth muscle cells.
- The precise signaling pathway for cGMP increases remains unclear.
Purpose of the Study:
- To investigate the role of protein kinase C (PKC) in cGMP elevation induced by ATP and bradykinin.
- To elucidate the signaling mechanisms linking EDRF agonists to cGMP production in endothelial cells.
Main Methods:
- Cultured porcine aortic endothelial cells were used.
- PKC activity was measured via substrate phosphorylation.
- cGMP levels were quantified using radioimmunoassay.
Main Results:
- Extracellular ATP and bradykinin simultaneously increased cGMP levels and PKC activity.
- PKC inhibitors (staurosporine, calphostin C, Cremophor EL) blocked ATP-induced cGMP elevation and reduced bradykinin-induced elevation.
- PKC activator (phorbol 12-myristate 13-acetate) elevated cGMP levels.
Conclusions:
- EDRF agonists elevate cGMP in endothelial cells through PKC stimulation.
- PKC plays a significant role in the signaling pathway of EDRF-mediated vasodilation.
Abstract:
Vasodilation by agents such as bradykinin and ATP is dependent on nitric oxide, the endothelium-dependent relaxing factor (EDRF). The release of EDRF results in elevation of cGMP in endothelial and smooth muscle cells (9). The signaling pathway that leads to increases in cGMP is not completely understood. The role of protein kinase C (PKC) in the elevation of cGMP induced by ATP and bradykinin was studied in cultured porcine aortic endothelial cells, by measuring PKC phosphorylation of a substrate and by measuring cGMP levels by radioimmunoassay. Extracellular ATP and bradykinin simultaneously elevated cGMP levels and PKC activity. The PKC inhibitors staurosporine, calphostin C, and Cremophor EL (T. Tamaoki and H. Nakano. Bio/Technology 8: 732-735, 1990; F. K. Zhao, L. F. Chuang, M. Israel, and R. Y. Chuang. Biochem. Biophys. Res. Commun. 159: 1359-1367, 1989) prevented the elevation of cGMP elicited by ATP and reduced that produced by bradykinin. Cremophor did not affect the elevation of cGMP by nitroprusside, an agent that directly increases guanylate cyclase activity (9). The PKC activator phorbol 12-myristate 13-acetate, but not a phorbol ester analog inactive on PKC, also elevated cGMP levels. These results suggest that EDRF agonists elevate cGMP in endothelial cells via PKC stimulation.
Related Concept Videos
Amplifying Signals via Second Messengers
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...
cAMP-dependent Protein Kinase Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway

